These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 31785096)
1. Identifying the variables that drive tamoxifen-independent CreERT2 recombination: Implications for microglial fate mapping and gene deletions. Van Hove H; Antunes ARP; De Vlaminck K; Scheyltjens I; Van Ginderachter JA; Movahedi K Eur J Immunol; 2020 Mar; 50(3):459-463. PubMed ID: 31785096 [TBL] [Abstract][Full Text] [Related]
2. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2. Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885 [TBL] [Abstract][Full Text] [Related]
3. Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues. Hameyer D; Loonstra A; Eshkind L; Schmitt S; Antunes C; Groen A; Bindels E; Jonkers J; Krimpenfort P; Meuwissen R; Rijswijk L; Bex A; Berns A; Bockamp E Physiol Genomics; 2007 Sep; 31(1):32-41. PubMed ID: 17456738 [TBL] [Abstract][Full Text] [Related]
5. Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse. Lau J; Minett MS; Zhao J; Dennehy U; Wang F; Wood JN; Bogdanov YD Mol Pain; 2011 Dec; 7():100. PubMed ID: 22188729 [TBL] [Abstract][Full Text] [Related]
6. A powerful transgenic tool for fate mapping and functional analysis of newly generated neurons. Zhang J; Giesert F; Kloos K; Vogt Weisenhorn DM; Aigner L; Wurst W; Couillard-Despres S BMC Neurosci; 2010 Dec; 11():158. PubMed ID: 21194452 [TBL] [Abstract][Full Text] [Related]
7. A comparative evaluation of the strengths and potential caveats of the microglial inducible CreER mouse models. Bedolla AM; McKinsey GL; Ware K; Santander N; Arnold TD; Luo Y Cell Rep; 2024 Jan; 43(1):113660. PubMed ID: 38217856 [TBL] [Abstract][Full Text] [Related]
8. Tmem119-EGFP and Tmem119-CreERT2 Transgenic Mice for Labeling and Manipulating Microglia. Kaiser T; Feng G eNeuro; 2019; 6(4):. PubMed ID: 31371457 [TBL] [Abstract][Full Text] [Related]
9. Transgenic Targeting of Kaiser T; Dattero J; Li L; Chen M; Jiang M; Harrahill A; Butovsky O; Feng G eNeuro; 2024 Jul; 11(7):. PubMed ID: 38926085 [TBL] [Abstract][Full Text] [Related]
10. VE-cadherin-CreERT2 transgenic mouse: a model for inducible recombination in the endothelium. Monvoisin A; Alva JA; Hofmann JJ; Zovein AC; Lane TF; Iruela-Arispe ML Dev Dyn; 2006 Dec; 235(12):3413-22. PubMed ID: 17072878 [TBL] [Abstract][Full Text] [Related]
11. Cx3cr1 Lee Y; Lee JW; Nam H; Yu SW Mol Brain; 2020 Jun; 13(1):88. PubMed ID: 32513210 [TBL] [Abstract][Full Text] [Related]